Literature DB >> 16481522

Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline.

Jean-Marc Rolain1, Frédéric Lambert, Didier Raoult.   

Abstract

In this study we have evaluated the in vitro activity of antibiotics against 13 new isolates of Coxiella burnetii using a real-time quantitative PCR assay. MICs against doxycycline ranged from 1 to 8 microg/mL, telithromycin from 0.5 to 2 microg/mL, and all strains had MICs > or = 8 microg/mL for erythromycin. We report that strains resistant to doxycycline exist either in humans or animals.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16481522     DOI： 10.1196/annals.1355.039

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


  9 in total

Review 1.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 2.  Coxiella burnetii: international pathogen of mystery.

Authors:  Amanda L Dragan; Daniel E Voth
Journal:  Microbes Infect       Date:  2019-09-28       Impact factor: 2.700

Review 3.  Antimicrobial therapies for Q fever.

Authors:  Gilbert J Kersh
Journal:  Expert Rev Anti Infect Ther       Date:  2013-09-27       Impact factor: 5.091

4.  Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates.

Authors:  A E Gregory; E J van Schaik; K E Russell-Lodrigue; A P Fratzke; J E Samuel
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

5.  Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis.

Authors:  Sarah Rebecca Porter; Guy Czaplicki; Jacques Mainil; Raphaël Guattéo; Claude Saegerman
Journal:  Int J Microbiol       Date:  2011-12-13

6.  Quantitative proteome profiling of C. burnetii under tetracycline stress conditions.

Authors:  Iosif Vranakis; Pieter-Jan De Bock; Anastasia Papadioti; Yannis Tselentis; Kris Gevaert; Georgios Tsiotis; Anna Psaroulaki
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

7.  Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever.

Authors:  M Gill Hartley; Isobel H Norville; Mark I Richards; Kay B Barnes; Kevin R Bewley; Julia Vipond; Emma Rayner; Andreas Vente; Stuart J Armstrong; Sarah V Harding
Journal:  Front Microbiol       Date:  2021-11-30       Impact factor: 5.640

Review 8.  A fatal case of disseminated chronic Q fever: a case report and brief review of the literature.

Authors:  Stephan P Keijmel; Ruud P H Raijmakers; Teske Schoffelen; Maria C W Salet; Chantal P Bleeker-Rovers
Journal:  Infection       Date:  2016-03-03       Impact factor: 3.553

9.  Genetic mechanisms of Coxiella burnetii lipopolysaccharide phase variation.

Authors:  Paul A Beare; Brendan M Jeffrey; Carrie M Long; Craig M Martens; Robert A Heinzen
Journal:  PLoS Pathog       Date:  2018-02-26       Impact factor: 6.823
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.